Sanara MedTech (NASDAQ:SMTI) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.12) by 50 percent. This is a 500 percent decrease over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $26.305 million which beat the analyst consensus estimate of $25.800 million by 1.96 percent. This is a 48.70 percent increase over sales of $17.690 million the same period last year.